НовостиBenzingaHC Wainwright & Co. Initiates Coverage On Eikon Therapeutics with Buy Rating, Announces Price Target of $23 HC Wainwright & Co. Initiates Coverage On Eikon Therapeutics with Buy Rating, Announces Price Target of $23 Benzinga 2026.10.16 10:11 (GMT+0) Открыть на Benzinga Другие новости